CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cellmediated protection from colitis

Gastroenterology

Volumn 142, Issue 2, 2012, Pages 335-345

  Heiseke, Alexander F ^a   Faul, Antonia C ^a   Lehr, Hansanton ^b   Förster, Irmgard ^c   Schmid, Roland M ^a   Krug, Anne B ^a   Reindl, Wolfgang ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Crohn's Disease; IBD; Mouse Model; TLR

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCL17; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 23; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL TRANSFER; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; ENTERITIS; HELPER CELL; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL;

EID: 84856231283     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.10.027     Document Type: Article

References (34)

1. D.K. Podolsky Inflammatory bowel disease N Engl J Med 347 2002 417 429
2. J.L. Coombes, K.R. Siddiqui, C.V. Arancibia-Carcamo et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism J Exp Med 204 2007 1757 1764
3. Y. Reiss, A.E. Proudfoot, C.A. Power et al. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin J Exp Med 194 2001 1541 1547
4. H. Saeki, K. Tamaki Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases J Dermatol Sci 43 2006 75 84
5. P. Vijayanand, K. Durkin, G. Hartmann et al. Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients J Immunol 184 2010 4568 4574
6. M. Inngjerdingen, B. Damaj, A.A. Maghazachi Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309 J Immunol 164 2000 4048 4054
7. T.L. Ness, J.L. Ewing, C.M. Hogaboam et al. CCR4 is a key modulator of innate immune responses J Immunol 177 2006 7531 7539
8. F. Sallusto, A. Lanzavecchia Mobilizing dendritic cells for tolerance, priming, and chronic inflammation J Exp Med 189 1999 611 614
9. V. Semmling, V. Lukacs-Kornek, C.A. Thaiss et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs Nat Immunol 11 2010 313 320
10. Q. Yuan, S.K. Bromley, T.K. Means et al. CCR4-dependent regulatory T cell function in inflammatory bowel disease J Exp Med 204 2007 1327 1334
11. I. Lee, L. Wang, A.D. Wells et al. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor J Exp Med 201 2005 1037 1044
12. J. Alferink, I. Lieberam, W. Reindl et al. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen J Exp Med 197 2003 585 599
13. S. Stutte, T. Quast, N. Gerbitzki et al. Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells Proc Natl Acad Sci U S A 107 2010 8736 8741
14. N.N. Kristensen, D. Brudzewsky, M. Gad et al. Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells Inflamm Bowel Dis 12 2006 612 618
15. H. Scheerens, E. Hessel, R. de Waal-Malefyt et al. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells Eur J Immunol 31 2001 1465 1474
16. F. Jugde, M. Alizadeh, C. Boissier et al. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis Eur Cytokine Netw 12 2001 468 477
17. K. Lahl, C. Loddenkemper, C. Drouin et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease J Exp Med 204 2007 57 63
18. B. Siegmund, F. Rieder, S. Albrich et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice J Pharmacol Exp Ther 296 2001 99 105
19. A. Izcue, S. Hue, S. Buonocore et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis Immunity 28 2008 559 570
20. O. Pabst, L. Ohl, M. Wendland et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine J Exp Med 199 2004 411 416
21. S. Melgar, M. Drmotova, E. Rehnstrom et al. Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis Cytokine 35 2006 275 283
22. S. Buonocore, P.P. Ahern, H.H. Uhlig et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology Nature 464 2010 1371 1375
23. M.C. Kullberg, D. Jankovic, C.G. Feng et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis J Exp Med 203 2006 2485 2494
24. E. Bettelli, Y. Carrier, W. Gao et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
25. P.P. Ahern, C. Schiering, S. Buonocore et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells Immunity 33 2010 279 288
26. Y. Ishida, T. Hayashi, T. Goto et al. Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis J Immunol 181 2008 4208 4218
27. F. Jimenez, M.P. Quinones, H.G. Martinez et al. CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B J Immunol 184 2010 5571 5581
28. S.G. Park, R. Mathur, M. Long et al. T regulatory cells maintain intestinal homeostasis by suppressing gammadelta T cells Immunity 33 2010 791 803
29. C. Mottet, H.H. Uhlig, F. Powrie Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells J Immunol 170 2003 3939 3943
30. D. Mucida, K. Pino-Lagos, G. Kim et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells Immunity 30 2009 471 472 author reply 472473
31. D. Cheatem, B.B. Ganesh, E. Gangi et al. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function Clin Immunol 131 2009 260 270
32. H. Kared, B. Leforban, R. Montandon et al. Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors Blood 112 2008 2575 2578
33. A. Yokota, H. Takeuchi, N. Maeda et al. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity Int Immunol 21 2009 361 377
34. J. Barahona-Garrido, J.K. Yamamoto-Furusho New treatment options in the management of IBD - focus on colony stimulating factors Biologics 2 2008 501 504